Bempedoic Acid: A New option for Statin-Intolerant Patients

Exploring Bempedoic Acid's Role in Preventing Cardiovascular Events

Mar 24, 2024

∙ Paid

Topline:

A recent subgroup analysis from the CLEAR Outcomes trial highlights bempedoic acid's significant potential in reducing major adverse cardiovascular events (MACE) among high-risk, statin-intolerant patients. This finding marks a pivotal moment for patients and healthcare providers, promising a new, effective treatment path for those previously l…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.